CapsoVision (CV) Free Cash Flow (2024 - 2025)
CapsoVision (CV) posted Free Cash Flow of -$7.7 million for Q4 2025, down 35.65% sequentially from -$5.7 million in Q3 2025, and down 46.54% YoY from -$14.4 million in Q4 2024.
CapsoVision (CV) Free Cash Flow (2024 - 2025) Analysis & Trends
CapsoVision has reported Free Cash Flow for 2 years, with the latest figure at -$7.7 million in Q4 2025.
- Quarterly Free Cash Flow fell 46.54% year-over-year to -$7.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$18.6 million (changed N/A YoY) and the FY2025 annual result came in at -$22.9 million, down 13.81% from the prior year.
- Free Cash Flow declined to -$7.7 million in Q4 2025 per CV's latest filing, from -$5.7 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$5.2 million in Q4 2024 and troughed at -$7.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 279.60 Mn |
| 10 | CapsoVision | 299.87 Mn | 290.80 Mn | 1.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.69 Mn |
| Dec 31, 2025 | -7.69 Mn |
| Sep 30, 2025 | -5.67 Mn |
| Sep 30, 2025 | -5.67 Mn |
| Dec 31, 2024 | -5.25 Mn |
| Dec 31, 2024 | -5.25 Mn |
| Sep 30, 2024 | -7.21 Mn |
| Sep 30, 2024 | -7.21 Mn |